• Accountable for the assessment of the therapeutic potential and clinical tractability of targets, and for clinical leadership in defining and executing the early development strategy.• Led matrix teams to deliver multiple phase 1 and enabling studies.• Experienced medical monitor and recognised as internal SME.• Member of clinical team accountable for the initial global filing of depemokimab.• Developed clinical target identification strategy across cardiovascular, renal and… Show more • Accountable for the assessment of the therapeutic potential and clinical tractability of targets, and for clinical leadership in defining and executing the early development strategy.• Led matrix teams to deliver multiple phase 1 and enabling studies.• Experienced medical monitor and recognised as internal SME.• Member of clinical team accountable for the initial global filing of depemokimab.• Developed clinical target identification strategy across cardiovascular, renal and metabolic therapeutic areas as part of 23andMe collaboration.• Chair of the Clinical Radiation Advisory Group; accountable for assessment of benefit:risk across GSK entire portfolio.• Chair of the Clinical Insight Seminars; a monthly seminar series where external experts discuss the clinical aspects of disease and associated challenges in drug development.• Committed to the professional development of colleagues as both a mentor and GMC appraiser. Show less

• Continuation of previous appointment to complete active research projects.

• Designed and executed multiple experimental studies investigating modulation of blood pressure. • Sub-investigator and faculty member at the NIHR Clinical Research Facility; a MHRA-accredited Phase 1 unit.• Lectured on the Clinical Pharmacology MSc; an FPM-approved course for the Certificate in Human Pharmacology.• Provided assessments for low-risk studies performed at King’s College London as member of the internal ethics committee.• Led collaboration with astrophysicists at… Show more • Designed and executed multiple experimental studies investigating modulation of blood pressure. • Sub-investigator and faculty member at the NIHR Clinical Research Facility; a MHRA-accredited Phase 1 unit.• Lectured on the Clinical Pharmacology MSc; an FPM-approved course for the Certificate in Human Pharmacology.• Provided assessments for low-risk studies performed at King’s College London as member of the internal ethics committee.• Led collaboration with astrophysicists at the University of Southampton which focused on the use of mathematical modelling to optimise cardiovascular risk reduction strategies. Work supported by the Alan Turing Institute. Show less

• Delivered tertiary centre hypertension and lipid clinics, with a focus on cardiovascular risk assessment and the prescribing of novel therapeutics.• Led multidisciplinary team accountable for out-of-hours management of acute undifferentiated illness.

• Co-opted member of technical committee responsible for updating NICE guideline NG136 covering "Hypertension in Adults".• Experienced in economic modelling approaches to determine QALY impact of medicines.

• Led multidisciplinary team accountable for out-of-hours management of acute undifferentiated illness.• Delivered tertiary outpatient clinics focused on challenging blood pressure disorders and gained experience of device therapies for hypertension management.• Developed expertise in cardiology patients with refractory heart failure and the diagnosis/management of chest pain.

• Read for PhD in Clinical Pharmacology investigating the "Proteomics of Aspirin Resistance".• Designed and delivered a low-intervention cohort study in patients with coronary artery disease.• Built and validated an LC-MS/MS assay to support a precision medicine clinical strategy.• First author publications spanning basic science, review articles and meta-analyses. • Prize winning conference presentation, peer-reviewed publication and PhD thesis.

• Rotations in Acute & General Medicine, Emergency Medicine, Critical Care and Anaesthetics.

• Rotations in Trauma & Orthopaedics, Emergency Medicine and Geriatrics.

• Rotations in HPB surgery, Haematology and Respiratory Medicine.